Use of pharmacotherapy in the treatment of aphasia

Brain and Language

Volumn 71, Issue 1, 2000, Pages 252-254

  Walker Batson, Delaina ^a  

^a TEXAS WOMAN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; DEXAMPHETAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; NOOTROPIC AGENT;

APHASIA; BRAIN INJURY; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; HUMAN; LONG TERM POTENTIATION; NERVE EXCITABILITY; NEUROMODULATION; NEUROTRANSMITTER RELEASE; SHORT SURVEY; SPEECH;

EID: 0034010826     PISSN: 0093934X     EISSN: None     Source Type: Journal    
DOI: 10.1006/brln.1999.2262     Document Type: Article

References (14)

1. Albert M. L., Bachman D. L., Morgan A. Pharmacotherapy for aphasia. Neurology. 38:1988;877-879.
2. Deitrich W. D., Alonso O., Busto R., Ginsberg M. D. The effect of amphetamine on functional brain activation in normal and post-infarcted rat. Stroke. 21:1990;147-150.
3. Feeney D. M. Pharmacological modulation of recovery after brain injury. CRCC Critical Reviews in Neurobiology. 3:1987;135-197.
4. Gold P. E., Delaney R. L., Merrin J. Modulation of long-term potentiation by peripherally administered amphetamine and epinephrine. Brain Research. 305:1984;103-107.
5. Goldstein L. B. Restorative neurology: Advances in pharmacotherapy for recovery after stroke. 1998;Futura, Armonk.
6. Hagemann G., Redecker C., Neumann-Haefelin T., Freund H. J., Witte O. W. Increased long-term potentiation in the surround of experimentally induced focal cortical infarction. Annals of Neurology. 44:1998;225-258.
7. Huber W., Willmes K., Poeck K., Van Vleymaen B., Deberdt W. Piracetam as an adjunct to language therapy for aphasia: A randomized double-blind placebo-controlled pilot study. Archives of Physical Medicine and Rehabilitation. 78:1997;245-250.
8. Kozlowsky D. W., James D. C., Schallert T. Use-dependent exaggeration of neuronal injury after unilateral sensorimotor cortex lesions. The Journal of Neuroscience. 15:1996;4776-4786.
9. Merzenich M. M., Kaas J. H., Wall J. Topographic reorganization of somatosensory cortical areas 3B and 1 in adult monkeys following restricted deafferentation. Neuroscience. 8:1983;33-55.
10. Sabe L., Salvarezza F., Garcia Cuerva A., Leiguarda R., Starkstein S. A randomized double-blind placebo controlled study of bromocriptine in nonfluent aphasia. Neurology. 45:1995;2272-2274.
11. 11C McN5652. Journal of Nuclear Medicine. 35:1994;85P.
12. Walker-Batson D. Pharmacotherapy in the treatment of aphasia. Goldstein L. B. Restorative neurology: Advances in pharmacotherapy for recovery after stroke. 1998;Futura, Armonk.
13. Walker-Batson, D. April 1999, Pharmacologic experimentation for motor and cognitive dysfunction: Clinical trials to promote recovery. Proceedings of 2nd World Congress in Neurological Rehabilitation, Toronto, Canada.
14. Walker-Batson D., Smith P., Curtis S., Unwin H., Greenlee R. G. Amphetamine paired with physical therapy accelerates recovery from stroke: Further evidence. Stroke. 26:1995;2254-2259.